PainCast

Author: Austin Williamson

  • Cervicogenic Headache Diagnosis and Treatment

    Cervicogenic Headache Diagnosis and Treatment

    [vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on November 16, 2021

    Dr. Antonio Rezoagli begins with a review of the anatomical locus for cervicogenic headache, including the intersection of sensory nerve fibers from the trigeminal nucleus and the upper cervical roots, and their contributions to referred pain. He moves on to the epidemiology and differential diagnosis of cervicogenic headache, including approaches to diagnosis and the use of anesthetic blockade to confirm a diagnosis. Dr. Rezoagli concludes by considering standard and experimental treatment options for cervicogenic headache.

    [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]

    [/vc_column_text][/vc_column][/vc_row]

  • Patient Observational Study on the use of a Patient Navigator

    Patient Observational Study on the use of a Patient Navigator

    [vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on November 9, 2021

    Dr. Amol Soin describes the results of a study on the use of a patient navigator. Dr. Soin thinks we can use digital technologies to improve patients’ experiences. Dr. Soin and his team investigated the use of a Patient Navigator to improve opioid compliance. They found that the best predictor of noncompliance was depression and anxiety. Navigator group patients also had lower pain scores, lower morphine milligram equivalents (MME), and lower discharge rates. However, causality still needs to be determined.

    [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]

    [/vc_column_text][/vc_column][/vc_row]

  • Pharmacological Advances in Opioid Therapy: The Role of Oliceridine in Pain Management

    Pharmacological Advances in Opioid Therapy: The Role of Oliceridine in Pain Management

    [vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on November 2, 2021

    Dr. Alex D. Pham discusses pharmacological advances in opioid therapy and the role of oliceridine. As the number of patients with pain has grown, so has the need for better pharmacological treatments. Oliceridine provides a compelling alternative because this compound that binds to mu-opioid receptors but are coupled to a Beta-arrestin inhibitor. This allows for analgesia with a reduced side effect profile. Overall, a literature analysis supports the use of oliceridine for pain management.

    [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]

    [/vc_column_text][/vc_column][/vc_row]

  • Current Landscape in Biologics

    Current Landscape in Biologics

    [vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on October 26, 2021

    Dr. Sairam Atluri discusses the current landscape in biologics in musculoskeletal and spinal disorders. Now, according to the FDA, no stem cells or other biologics can be used at all outside of approved clinical trials. Dr. Atluri argues that stem-cell based interventions are not as negative as some reviews suggest, and instead complications may be due to medical practitioners operating outside of their scope of training.

    [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]

    [/vc_column_text][/vc_column][/vc_row]

  • Spinal Cord Stimulation for Painful Diabetic Peripheral Neuropathy

    Spinal Cord Stimulation for Painful Diabetic Peripheral Neuropathy

    [vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on October 20, 2021

    Dr. Alex D. Pham describes how spinal cord stimulation can be used for painful diabetic peripheral neuropathy. However, traditional treatments are oftentimes discontinued due to poor tolerability, low patient satisfaction, etc. What role is there for spinal cord stimulators for diabetic peripheral neuropathy. A large database review demonstrates that clinical studies indeed support the use of spinal cord stimulation to improve pain and patient outcomes.

    [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]

    [/vc_column_text][/vc_column][/vc_row]

  • Raj/Racz Lecture Series

    Raj/Racz Lecture Series

    [vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on October 12, 2021

    Dr. Aaron Calodney introduces the Raj/Racz Distinguished Lecture Series. This series has been a part of every ASIPP meeting since 2016. Dr. Calodney describes the work and legacy of Dr. Phulchand Raj, as well as the personal impact Dr. Raj had on his own life and career. Dr. Calodney also describes the life and work of Dr. Gabor Bela Racz. Dr. Calodney also introduced the keynote speakers, Dr. David Schultz and Dr. Laxmaiah Manchikanti.

    [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]

    [/vc_column_text][/vc_column][/vc_row]

  • DRG and Chronic Pain

    DRG and Chronic Pain

    [vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on October 11, 2021

    Dr. Alex D. Pham discusses the dorsal root ganglion (DRG) and chronic pain. Chronic neuropathic pain is widespread and difficult to treat. However, targeting the DRG has begun to show promising effects in pain alleviation. Dr. Pham and his colleagues conducted a systemic literature search and found several promising case reports that support the use of DRG stimulation. Overall, this developing technique may allow for a precise approach to chronic pain management.

    [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]

    [/vc_column_text][/vc_column][/vc_row]

  • Digital Solutions to Identify Pain Patients in the Community

    Digital Solutions to Identify Pain Patients in the Community

    [vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on October 6, 2021

    Dr. Nilesh Patel discusses digital solutions to identify pain patient in the community, as well as how to manage them efficiently and maintain their therapy. Dr. Patel discusses how our solutions for pain management are indeed getting better, and utilization of these solutions are also increasing. However, people are still in pain and therapy sustainability is critical. Reaching patients in the digital environment may be one solution.

    [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]

    [/vc_column_text][/vc_column][/vc_row]

  • The Effects of CAC Policy On Our Survival: Epidural Interventions

    The Effects of CAC Policy On Our Survival: Epidural Interventions

    [vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on October 1, 2021

    At this breakfast symposium, several experts discuss issues in pain medicine, including the use of epidurals and steroids. Legislative processes, such as contacting Senators and members of Congress, are also discussed. The panel also stresses the importance of the audience’s participation in these processes so that pain management guidelines are appropriate.

    [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]

    [/vc_column_text][/vc_column][/vc_row]

  • CALSIPP

    CALSIPP

    [vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on September 23, 2021

    Dr. Ripu Arora, the current CALSIPP president, is a pain management physician. He is also interested in how health care policies are created. He is passionate about pain management and takes a multidisciplinary and holistic approach to his medicine. He looks forward to educating the next generation of interventional pain management specialists.

    Learn more at calsipp.com

    [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]

    [/vc_column_text][/vc_column][/vc_row]